Tighter controls imposed on Pregabalin sale, distribution amid abuse concerns
The Union health ministry has imposed stricter controls on the sale and distribution of Pregabalin due to rising concerns about its misuse. The drug, which is commonly prescribed for various chronic conditions, will now require a prescription from a registered medical practitioner. Retailers must maintain a detailed register of prescriptions and sales, and violations will lead to penalties under existing drug laws.
- ▪Pregabalin is now classified under the stricter Schedule H1 category of the Drugs Rules, 1945.
- ▪The government cited increasing misuse of Pregabalin for its sedative and euphoric effects.
- ▪Retail chemists are required to keep a separate register for Pregabalin prescriptions and sales.
Opening excerpt (first ~120 words) tap to expand
Tighter controls imposed on Pregabalin sale, distribution amid abuse concernsPregabalin is commonly prescribed for chronic pain, neuropathies, fibromyalgia, and certain neurological conditionsPublished on: May 22, 2026 11:37 AM ISTBy Ridhima GuptaShare viaCopy link The Union health ministry on Friday brought the widely prescribed drug Pregabalin under the stricter Schedule H1 category of the Drugs Rules, 1945, imposing tighter controls on its sale and distribution amid growing concerns over its misuse and abuse, particularly among youth.The government highlighted the increasing misuse of the drug for its sedative, euphoric, and dissociative effects.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Hindustan Times — Top.
Discussion
0 commentsMore from Hindustan Times — Top
